Clinical Trial Results:
A randomized, adaptive-design dose finding study to assess the antiviral efficacy and
safety of NIM811 administered in combination with Standard of Care (SOC) for 12 weeks in relapsed HCV-1 infected patients
Summary
|
|
EudraCT number |
2009-009995-11 |
Trial protocol |
DE ES IT BE NL |
Global completion date |
27 Apr 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
16 Sep 2016
|
First version publication date |
16 Sep 2016
|
Other versions |
|
Summary report(s) |
CNIM811B2202.CTR.18Aug2016 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.